Patent details

Basic Information

Publication number:

EP3274332

PCT Application Number:

EP2016056267

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167109974

PCT Publication Number:

WO2016150966

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLINE FORMS OF CABOZANTINIB PHOSPHATE AND CABOZANTINIB HYDROCHLORIDE

French Title of Invention:

FORMES CRYSTALLINES DE CABOZANTINIB PHOSPHATE ET CABOZANTINIB HYDROCHLORIDE

German Title of Invention:

CRYSTALLINE FORMEN VON CABOZANTINIB-PHOSPHAT UND CABOZANTINIB-HYDROCHLORID

SPC Number:

Dates

Filing date:

22/03/2016

Grant date:

19/12/2018

EP Publication Date:

31/01/2018

PCT Publication Date:

29/09/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/12/2018

EP B1 Publication Date:

19/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/03/2019

Expiration date:

22/03/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2018

 

 

Name:

Sandoz AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

SCHREINER, Erwin, Paul

Address:

Austria (AT)

2

Name:

STEFINOVIC, Marijan

Address:

Austria (AT)

Priority

Priority Number:

15160869

Priority Date:

25/03/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/47; A61P 35/00; C07D 215/22;

Publication

European Patent Bulletin

Issue number:

201851

Publication date:

19/12/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages